STRO insider transactions
Sutro Biopharma Inc. (STRO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for STRO
- SEC Form 4 filed by Director Wigginton Jon Marc4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Petree Daniel H4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Panek James P4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Lobacki Joseph M4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Jagpal Sukhi4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Hunter Heidi4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Dybbs Michael4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Matsui Connie4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CFO Chow Gregory K. converted options into 2,500 shares, increasing direct ownership by 112% to 4,725 units (SEC Form 4) (withholding obligation)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- Chief Admin. Ofcr. & GC Pauling David converted options into 675 shares and covered exercise/tax liability with 277 shares, increasing direct ownership by 4% to 9,748 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- Chief Executive Officer Chung Jane converted options into 788 shares and covered exercise/tax liability with 282 shares, increasing direct ownership by 2% to 21,285 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- Chief Admin. Ofcr. & GC Pauling David converted options into 3,698 shares and covered exercise/tax liability with 1,521 shares, increasing direct ownership by 30% to 9,350 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CHIEF SCIENTIFIC OFFICER Gerber Hans-Peter converted options into 3,968 shares and covered exercise/tax liability with 1,633 shares, increasing direct ownership by 33% to 9,518 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by CFO Chow Gregory K.4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- Chief Executive Officer Chung Jane converted options into 10,938 shares and covered exercise/tax liability with 4,050 shares, increasing direct ownership by 50% to 20,779 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Wigginton Jon Marc4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Petree Daniel H4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Panek James P4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Matsui Connie4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Lobacki Joseph M4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Jagpal Sukhi4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Hunter Heidi4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Dybbs Michael4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Chief Admin. Ofcr. & GC Pauling David4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Gerber Hans-Peter4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by CFO Chow Gregory K.4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- Chief Executive Officer Chung Jane converted options into 2,500 shares and covered exercise/tax liability with 894 shares, increasing direct ownership by 13% to 13,891 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CHIEF SCIENTIFIC OFFICER Gerber Hans-Peter bought $13,607 worth of shares (17,000 units at $0.80), increasing direct ownership by 31% to 71,832 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CFO Chow Gregory K. bought $15,998 worth of shares (19,750 units at $0.81) (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- Chief Executive Officer Chung Jane bought $10,011 worth of shares (12,500 units at $0.80), increasing direct ownership by 11% to 122,850 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- Director Matsui Connie bought $39,950 worth of shares (50,000 units at $0.80) (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- Chief Admin. Ofcr. & GC Pauling David bought $9,993 worth of shares (12,504 units at $0.80), increasing direct ownership by 21% to 71,737 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CHIEF SCIENTIFIC OFFICER Gerber Hans-Peter converted options into 37,500 shares and covered exercise/tax liability with 13,417 shares, increasing direct ownership by 78% to 54,832 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- Amendment: New insider Pauling David claimed ownership of 56,733 shares (SEC Form 3)3/A - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- Chief Business Officer Leyman Barbara converted options into 25,000 shares and covered exercise/tax liability with 8,944 shares (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- Chief Executive Officer Chung Jane converted options into 18,750 shares and covered exercise/tax liability with 6,708 shares, increasing direct ownership by 12% to 110,350 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Wigginton Jon Marc4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Petree Daniel H4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Panek James P4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Matsui Connie4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Lobacki Joseph M4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Jagpal Sukhi4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Hunter Heidi4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Director Dybbs Michael4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by CFO Chow Gregory K.4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 3 filed by new insider Chow Gregory K.3 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CFO AND SECRETARY Albini Edward C converted options into 44,719 shares and covered exercise/tax liability with 15,995 shares, increasing direct ownership by 22% to 160,805 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CHIEF PEOPLE & COMM. OFFICER Fitzpatrick Linda A converted options into 37,849 shares and covered exercise/tax liability with 13,538 shares, increasing direct ownership by 25% to 119,744 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CHIEF TECH OP OFFICER Srinivasan Venkatesh converted options into 2,500 shares and covered exercise/tax liability with 894 shares, increasing direct ownership by 3% to 53,686 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CHIEF MEDICAL OFFICER Borgman Anne Elizabeth covered exercise/tax liability with 24,709 shares and converted options into 69,063 shares, increasing direct ownership by 84% to 97,452 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CHIEF TECH OP OFFICER Srinivasan Venkatesh converted options into 21,250 shares and covered exercise/tax liability with 7,603 shares, increasing direct ownership by 36% to 52,080 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Chung Jane4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Gerber Hans-Peter4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Chief Business Dev. Officer Leyman Barbara4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by CHIEF TECH OP OFFICER Srinivasan Venkatesh4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- SEC Form 4 filed by Chief Admin. Ofcr. & GC Pauling David4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- New insider Pauling David claimed ownership of 98,758 shares (SEC Form 3)3 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CEO Newell William J converted options into 18,750 shares and covered exercise/tax liability with 6,708 shares, increasing direct ownership by 4% to 292,531 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CHIEF PEOPLE & COMM. OFFICER Fitzpatrick Linda A converted options into 8,750 shares and covered exercise/tax liability with 3,594 shares, increasing direct ownership by 6% to 95,433 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)
- CFO AND SECRETARY Albini Edward C converted options into 8,750 shares and covered exercise/tax liability with 3,594 shares, increasing direct ownership by 4% to 132,081 units (SEC Form 4)4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)